Weather threats to drug production facilities examined in study

A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster declaration was declared. About 34% of facilities were in such areas annually during the study period. Researchers said the findings demonstrate an urgent need for supply chain transparency, strategic allocation of production, and disaster risk management strategies to prevent future health care disruptions in the U.S.
Related News Articles
Headline
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a…
Headline
The Department of Commerce Sept. 24 released a notice seeking public comment on an investigation it launched Sept. 2 on imports of personal protective…
Headline
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a…
Headline
The Centers for Disease Control and Prevention Sept. 18 issued a health advisory on a new outbreak of Ebola in the Democratic Republic of the Congo. There are…
Headline
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with…
Headline
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…